Erectile function and sexual satisfaction before and after penile prosthesis implantation in radical prostatectomy patients: a comparison with patients with vasculogenic erectile dysfunction.

Modern utilization of penile prosthesis surgery: a national claim registry analysis. Int J Impot Res (2014) 0.82

Penile prosthesis surgery in the management of erectile dysfunction. Arab J Urol (2013) 0.81

Prostate cancer and sexual function. World J Mens Health (2012) 0.81

Postprostatectomy Erectile Dysfunction: A Review. World J Mens Health (2016) 0.81

Prevention and management of post prostatectomy erectile dysfunction. Transl Androl Urol (2015) 0.78

Prostate cancer survivorship: Implementation of survivorship care plans to meet the mandate and enhance urologic practice through collaborative care. Rev Urol (2016) 0.75

Patient and partner outcome of inflatable and semi-rigid penile prosthesis in a single institution. Int Braz J Urol (2015) 0.75

Post-prostatectomy erectile dysfunction: contemporary approaches from a US perspective. Res Rep Urol (2014) 0.75

Pharmacologic and surgical therapies for sexual dysfunction in male cancer survivors. Transl Androl Urol (2015) 0.75

Surgical Techniques for Managing Post-prostatectomy Erectile Dysfunction. Curr Urol Rep (2017) 0.75

Interventions to address sexual problems in people with cancer. Curr Oncol (2017) 0.75

Active surveillance for low-risk prostate cancer worldwide: the PRIAS study. Eur Urol (2012) 4.48

Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational study. Eur Urol (2012) 3.07

Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population. Eur Urol (2011) 1.87

[Penile prostheses and infection]. Prog Urol (2002) 1.40

[Laparoscopic sacral colpopexy: comparison of nonresorbable prosthetic tape (Mersuture) and a SIS collagen matrix (Surgisis ES)]. Prog Urol (2005) 1.38

Six years' experience with high-intensity focused ultrasonography for prostate cancer: oncological outcomes using the new 'Stuttgart' definition for biochemical failure. BJU Int (2010) 0.89

Combination of doxazosin and sildenafil exerts an additive relaxing effect compared with each compound alone on human cavernosal and prostatic tissue. J Sex Med (2008) 0.85

Salvage radiotherapy after high-intensity focused ultrasound treatment for localized prostate cancer: feasibility, tolerance and efficacy. Can Urol Assoc J (2011) 0.84

[Penile protheses multicentre practice evaluation, results after 282 procedures]. Prog Urol (2007) 0.83

[Recommendations to general practice doctors for first line management of erectile dysfunction]. Prog Urol (2005) 0.83

[Paraneoplastic urticarial vasculitis and renal carcinoma]. Prog Urol (2003) 0.83

[Small intestinal submucosa (SIS): prospects in urogenital surgery]. Prog Urol (2005) 0.82

[What is the objective of second-line chemotherapy after failure of first-line chemotherapy in hormone-resistant metastatic prostate?]. Prog Urol (2006) 0.79

Predictive factors of oncologic outcomes in patients who do not achieve undetectable prostate specific antigen after radical prostatectomy. J Urol (2013) 0.79

Clinical outcomes after salvage radiotherapy without androgen deprivation therapy in patients with persistently detectable PSA after radical prostatectomy: results from a national multicentre study. World J Urol (2013) 0.78

[Pelvic pain caused by bladder leiomyoma: diagnostic and radiologic difficulties]. Prog Urol (2002) 0.77

Treatment of calcinosis cutis by extracorporeal shock-wave lithotripsy. J Am Acad Dermatol (2011) 0.77

Gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the urothelium: a pilot study. Anticancer Res (2003) 0.76

[Prognostic value of stromal immunolabelling by MMP-2, MT1-MMP and TIMP-2 in clinically localized prostate cancer]. Prog Urol (2005) 0.76

[Study of the prognostic value of DNA ploidy and proliferation index (Ki-67) in renal cell carcinoma with venous thrombus]. Prog Urol (2003) 0.75

[CAT Scan in hormone-independent prostate cancer]. Prog Urol (2002) 0.75

[Primary adenocarcinoma of the bladder and renal transplantation]. Prog Urol (2003) 0.75

[Biopsy technique and biopsy schemes for a first series of prostatic biopsies]. Prog Urol (2004) 0.75

[Value of endovaginal ultrasound to explain voiding disorders after TVT (Tension-free Vaginal Tape)]. Prog Urol (2003) 0.75

[Hormonal therapy in metastatic prostatic cancer]. Prog Urol (2003) 0.75

[Cell ploidy: predictive factor of locally advanced prostate cancer]. Prog Urol (2007) 0.75

Subcutaneous interleukin-2 and interferon-alpha in metastatic renal cell carcinoma: results of a French regional experience in Languedoc. Am J Clin Oncol (2006) 0.75

[Testicular microlithiasis and cancer of the testis]. Prog Urol (2002) 0.75

[Endocrine therapy for localized or locally advanced prostate cancer]. Prog Urol (2004) 0.75

[Quality of life assessment after TVT (tension-free vaginal tape) based on 3 different questionnaires]. Prog Urol (2005) 0.75

[National prospective survey on the surgical quality of renal transplants in France. Study conducted by the Association Française d'Urologie Transplantation Committee]. Prog Urol (2007) 0.75